Kendall Law Group, led by former federal judge Joe Kendall, is investigating Immucor, Inc. (NASDAQ: BLUD) for shareholders in connection with the proposed acquisition by investment funds managed by TPG Capital. The national securities firm’s investigation seeks to determine whether Immucor and its Board breached their fiduciary duties by entering into the agreement without properly shopping for a deal that would provide better value for shareholders. If you are an Immucor shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at firstname.lastname@example.org. On July 5, 2011, Immucor announced the definitive merger agreement under which the company would be acquired by investment funds managed by TPG Capital, in a transaction valued at approximately $1.973 billion. Under the terms of the agreement, Immucor stockholders will receive $27.00 in cash for each share of Immucor/BLUD common stock held. Immucor shares were up to $27.20 in premarket trading, above the offer price of $27.00 a share. In addition, according to Thompson/First Call, analysts have set a price target as high as $28.00 per share for Immucor’s stock. The firm’s investigation seeks to determine whether Immucor and its Board undertook a fair process in negotiating the deal. Kendall Law Group was founded by a former federal judge, includes a former United States Attorney, prosecutors and securities lawyers who are experienced in complex securities litigation. The firm has been counsel in numerous merger and acquisition cases nationwide, including some of the largest transactions in the United States.
Shares of Immucor (Nasdaq:BLUD) have taken a tremendous swing upward. The stock is trading at $26.96 as of 9:31 a.m. ET, 30.1% above Friday's closing price of $20.73. Volume is at 1.8 million, 3.9 times the daily average of 464,400.